Cargando…

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances

OBJECTIVES: Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting statistically significant efficacy for clinical outcomes for alteplase use 3–4.5 hours after stroke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alper, Brian Scott, Foster, Gary, Thabane, Lehana, Rae-Grant, Alex, Malone-Moses, Meghan, Manheimer, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548536/ https://www.ncbi.nlm.nih.gov/pubmed/32430395 http://dx.doi.org/10.1136/bmjebm-2020-111386

Ejemplares similares

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China
por: Zheng, Huaguang, et al.
Publicado: (2020)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

Bolus-Infusion Delays of Alteplase during Thrombolysis in Acute Ischaemic Stroke and Functional Outcome at 3 Months
por: Acheampong, Paul, et al.
Publicado: (2014)

Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms
por: Urrutia, Victor C., et al.
Publicado: (2018)

Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
por: Kikuchi, Kiyoshi, et al.
Publicado: (2018)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
por: Fanikos, John, et al.
Publicado: (2021)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
por: Chen, Jigang, et al.
Publicado: (2023)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
por: Pan, Yuanmei, et al.
Publicado: (2021)

Effect of Apixaban Pretreatment on Alteplase-Induced Thrombolysis: An In Vitro Study
por: Thalerová, Sandra, et al.
Publicado: (2021)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis
por: Kikuchi, Kiyoshi, et al.
Publicado: (2017)

Using alteplase nephrostomy tube installation for thrombolysis of ureter tract clot obstruction
por: Lin, Paoyan, et al.
Publicado: (2021)

Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke
por: Zhao, Hong-Ying, et al.
Publicado: (2022)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Normal Appearing Ischaemic Brain Tissue on CT and Outcome After Intravenous Alteplase
por: Mair, Grant, et al.
Publicado: (2022)

Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China
por: Pan, Yuesong, et al.
Publicado: (2014)

Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis
por: Lu, Tao, et al.
Publicado: (2018)

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
por: Emberson, Jonathan, et al.
Publicado: (2014)

Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke
por: Wu, Simiao, et al.
Publicado: (2020)

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
por: Ezzeldin, Mohamad, et al.
Publicado: (2023)

Successful thrombolysis for acute ischaemic stroke in haemodialysis
por: Power, Albert, et al.
Publicado: (2010)

Safety and Clinical Outcome of Thrombolysis in Ischaemic Stroke Using a Perfusion CT Mismatch between 3 and 6 Hours
por: Sztriha, Laszlo K., et al.
Publicado: (2011)

Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
por: Nie, Ximing, et al.
Publicado: (2021)

Alteplase for Acute Ischemic Stroke Beyond 3 hours: Enthusiasm Outpaces Evidence
por: Garg, Ravi
Publicado: (2021)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
por: Tan, Ge, et al.
Publicado: (2017)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Subcutaneous haematomas following thrombolysis treatment for ischaemic stroke
por: Thirugnanachandran, Tharani, et al.
Publicado: (2012)

Reasons and evolution of non-thrombolysis in acute ischaemic stroke
por: Reiff, T, et al.
Publicado: (2017)

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
por: Sandercock, Peter, et al.
Publicado: (2011)

Alteplase for acute ischemic stroke: 2 years in a community hospital without previous experience in stroke thrombolysis
por: Estella, A, et al.
Publicado: (2008)

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial
por: Koga, Masatoshi, et al.
Publicado: (2014)

Spontaneous Splenic Rupture Following Intravenous Thrombolysis with Alteplase Applied as Stroke Therapy – Case Report and Review of Literature
por: Aleksic-Shihabi, Anka, et al.
Publicado: (2016)

A case of intra-arterial thrombolysis with alteplase in a patient with hypothenar hammer syndrome but without underlying aneurysm
por: Shukla, Harshal, et al.
Publicado: (2018)

Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020)

Effects of intravenous thrombolysis with alteplase combined with edaravone on cerebral hemodynamics and T lymphocyte level in patients with acute cerebral infarction
por: Li, Xiu-Xiu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k8u4e036eivl2ra835ajou5ht7